Abstract
Gastric cancer is the fifth most common cancer and the third most common cause of cancer death globally. Advanced disease is often metastatic to the peritoneum, liver, and lung. Bone involvement is rare, and bone marrow dissemination is even rarer. Hematological abnormalities may arise as complications of metastatic gastric cancer. Therefore, knowledge about the possibility of gastric cancer spreading to bone marrow and causing hematological complications is necessary.